Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Amber Therapeutics logo

Amber Therapeutics

Recent Finacing

Series A

Recent Raise

$101.9M

Amber Therapeutics develops Amber-UI, an adaptive neuromodulation therapy targeting the pudendal nerve using the fully implantable Picostim system to sense and stimulate physiology for treating mixed urinary incontinence.

Founded 2021
England, United Kingdom
11-50
Private
amber-tx.com

Highlights

Focus Areas

Biotechnology
Therapeutics

Recent Investors

F-Prime Capital logo
Lightstone Ventures logo
8VC logo
Oxford Science Enterprises logo
New Enterprise Associates logo
Intuitive Ventures logo

Financials

$101.9M

Total Raised

1

Funding round

6

Investors